Phillip Pang, EVP & Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 29,136 shares at $10.05 ($293K) on 2024-02-22, disclosed to the SEC on 2024-02-26.
Scheduled sale ($293k) by EVP & Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.05 | 14,568 | $146K | 50.0% |
| 2 | $10.05 | 14,568 | $146K | 50.0% |
| Total | $10.05 avg | 29,136 | $293K | 100% |
| Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |
| VIR | SELL | 2023-02-21 | $142K | — | Filing → |